TCALvsREVSETF Comparison
T. Rowe Price Capital Appreciation Premium Income ETF
T. Rowe Price Capital Appreciation Premium Income ETF (TCAL) belongs to the Options Strategies segment. Columbia Research Enhanced Value ETF (REVS) is part of the US Large Cap Value segment. TCAL's top 3 sector exposures are Industrials, Health Care and Information Technology. In contrast, REVS's top sector exposures are Financials, Information Technology and Industrials. TCAL is more expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.19% for REVS. TCAL is down -1.89% year-to-date (YTD) with +$76M in YTD flows. REVS performs better with 13.18% YTD performance, and +$143M in YTD flows. Run a side-by-side ETF comparison of TCAL and REVS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
TCAL vs REVS performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TCAL REVS | +1.66%+3.57% | -1.21%+12.54% | -1.89%+13.18% | +0.32%+26.66% | n/a+67.22% | n/a+74.68% |
| Flows | TCAL REVS | -$7M+$9M | +$16M+$69M | +$76M+$143M | +$222M+$199M | -+$244M | -+$258M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TCAL REVS | +10.10%+12.20% | +8.42%+11.30% | n/a+13.16% | n/a+15.12% |
| Max drawdown | TCAL REVS | -4.08%-2.42% | -7.17%-6.87% | n/a-16.16% | n/a-17.78% |
| Max drawdown duration | TCAL REVS | 29d14d | 102d66d | n/a211d | n/a448d |
TCAL | REVS | |
Last sale 6/12/2026 at 1:30 PM | $22.25 | $31.96 |
| Previous close 06/11/2026 | $22.20 | $31.63 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
TCAL | REVS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
TCAL | REVS | |
|---|---|---|
| Last price | $22.25 | $31.96 |
| 1D performance | +0.23% | +1.04% |
| AuM | $269.06 M | $311.94 M |
| E/R | 0.34% | 0.19% |
TCAL | REVS | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | Columbia Threadneedle Investments |
| Benchmark | - | Beta Advantage Research Enhanced U.S. Value Index |
| N° of holdings | 87 | 277 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | March 26, 2025 | September 25, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
